PFE logo

Pfizer (PFE) Cash from operations

annual CFO:

$12.74B+$4.04B(+46.48%)
December 31, 2024

Summary

  • As of today (May 29, 2025), PFE annual cash flow from operations is $12.74 billion, with the most recent change of +$4.04 billion (+46.48%) on December 31, 2024.
  • During the last 3 years, PFE annual CFO has fallen by -$19.84 billion (-60.88%).
  • PFE annual CFO is now -60.88% below its all-time high of $32.58 billion, reached on December 31, 2021.

Performance

PFE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

quarterly CFO:

$2.33B-$4.39B(-65.26%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE quarterly cash flow from operations is $2.33 billion, with the most recent change of -$4.39 billion (-65.26%) on March 29, 2025.
  • Over the past year, PFE quarterly CFO has increased by +$1.25 billion (+114.22%).
  • PFE quarterly CFO is now -79.33% below its all-time high of $11.30 billion, reached on June 1, 2021.

Performance

PFE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

TTM CFO:

$13.99B+$1.25B(+9.77%)
March 29, 2025

Summary

  • As of today (May 29, 2025), PFE TTM cash flow from operations is $13.99 billion, with the most recent change of +$1.25 billion (+9.77%) on March 29, 2025.
  • Over the past year, PFE TTM CFO has increased by +$5.41 billion (+63.08%).
  • PFE TTM CFO is now -59.55% below its all-time high of $34.58 billion, reached on March 1, 2022.

Performance

PFE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PFE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.5%+114.2%+63.1%
3 y3 years-60.9%-64.3%-59.5%
5 y5 years+1.2%-25.5%-0.2%

PFE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-60.9%+46.5%-72.8%+231.1%-59.5%+74.8%
5 y5-year-60.9%+46.5%-79.3%+231.1%-59.5%+74.8%
alltimeall time-60.9%+1843.3%-79.3%+136.7%-59.5%>+9999.0%

PFE Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.33B(-65.3%)
$13.99B(+9.8%)
Dec 2024
$12.74B(+46.5%)
$6.72B(+0.1%)
$12.74B(+13.1%)
Sep 2024
-
$6.71B(-477.0%)
$11.26B(+40.7%)
Jun 2024
-
-$1.78B(-263.4%)
$8.01B(-6.7%)
Mar 2024
-
$1.09B(-79.2%)
$8.58B(-1.4%)
Dec 2023
$8.70B(-70.3%)
$5.24B(+51.6%)
$8.70B(-27.8%)
Sep 2023
-
$3.46B(-386.1%)
$12.04B(-17.3%)
Jun 2023
-
-$1.21B(-199.7%)
$14.56B(-39.2%)
Mar 2023
-
$1.21B(-85.9%)
$23.94B(-18.2%)
Dec 2022
$29.27B(-10.2%)
$8.58B(+43.7%)
$29.27B(+10.0%)
Sep 2022
-
$5.97B(-26.9%)
$26.60B(-15.4%)
Jun 2022
-
$8.17B(+24.9%)
$31.45B(-9.0%)
Mar 2022
-
$6.54B(+10.6%)
$34.58B(+6.1%)
Dec 2021
$32.58B(+126.2%)
$5.91B(-45.4%)
$32.58B(+0.9%)
Sep 2021
-
$10.83B(-4.2%)
$32.29B(+37.1%)
Jun 2021
-
$11.30B(+149.0%)
$23.55B(+49.0%)
Mar 2021
-
$4.54B(-19.3%)
$15.81B(+9.8%)
Dec 2020
$14.40B(+14.4%)
$5.63B(+169.1%)
$14.40B(+14.8%)
Sep 2020
-
$2.09B(-41.2%)
$12.55B(-16.2%)
Jun 2020
-
$3.56B(+13.5%)
$14.97B(+6.7%)
Mar 2020
-
$3.13B(-16.9%)
$14.02B(+11.4%)
Dec 2019
$12.59B(-20.5%)
$3.77B(-16.4%)
$12.59B(-7.1%)
Sep 2019
-
$4.51B(+72.7%)
$13.56B(-5.2%)
Jun 2019
-
$2.61B(+53.8%)
$14.31B(-8.0%)
Mar 2019
-
$1.70B(-64.2%)
$15.54B(-1.8%)
Dec 2018
$15.83B(-5.8%)
$4.74B(-9.9%)
$15.83B(-12.9%)
Sep 2018
-
$5.26B(+36.7%)
$18.18B(+2.1%)
Jun 2018
-
$3.85B(+94.0%)
$17.81B(+3.5%)
Mar 2018
-
$1.98B(-72.0%)
$17.20B(+2.4%)
Dec 2017
$16.80B(+3.8%)
$7.09B(+45.0%)
$16.80B(+6.7%)
Sep 2017
-
$4.89B(+50.9%)
$15.75B(+1.0%)
Jun 2017
-
$3.24B(+104.5%)
$15.60B(-2.3%)
Mar 2017
-
$1.58B(-73.8%)
$15.97B(-1.4%)
Dec 2016
$16.19B(+10.2%)
$6.04B(+27.5%)
$16.19B(+7.6%)
Sep 2016
-
$4.74B(+31.4%)
$15.05B(-1.8%)
Jun 2016
-
$3.61B(+99.4%)
$15.33B(-3.1%)
Mar 2016
-
$1.81B(-63.1%)
$15.82B(+7.7%)
Dec 2015
$14.69B(-14.0%)
$4.90B(-2.4%)
$14.69B(-4.6%)
Sep 2015
-
$5.02B(+22.7%)
$15.39B(+3.8%)
Jun 2015
-
$4.09B(+501.5%)
$14.83B(+0.0%)
Mar 2015
-
$680.00M(-87.9%)
$14.83B(-13.2%)
Dec 2014
$17.08B(-3.4%)
$5.60B(+25.5%)
$17.08B(-0.7%)
Sep 2014
-
$4.46B(+9.2%)
$17.21B(-7.7%)
Jun 2014
-
$4.09B(+39.3%)
$18.65B(+1.8%)
Mar 2014
-
$2.94B(-48.7%)
$18.32B(+3.6%)
Dec 2013
$17.68B(+5.6%)
$5.72B(-3.0%)
$17.68B(+4.6%)
Sep 2013
-
$5.90B(+57.0%)
$16.91B(+5.6%)
Jun 2013
-
$3.76B(+63.1%)
$16.01B(-1.6%)
Mar 2013
-
$2.30B(-53.5%)
$16.27B(-2.8%)
Dec 2012
$16.75B(-17.3%)
$4.95B(-1.1%)
$16.75B(-1.8%)
Sep 2012
-
$5.00B(+24.4%)
$17.06B(+3.4%)
Jun 2012
-
$4.02B(+45.0%)
$16.50B(-10.2%)
Mar 2012
-
$2.77B(-47.3%)
$18.37B(-9.2%)
Dec 2011
$20.24B(+76.7%)
$5.26B(+18.5%)
$20.24B(-4.7%)
Sep 2011
-
$4.44B(-24.7%)
$21.24B(-9.6%)
Jun 2011
-
$5.90B(+27.1%)
$23.48B(+4.6%)
Mar 2011
-
$4.64B(-25.8%)
$22.46B(+96.1%)
Dec 2010
$11.45B(-30.9%)
$6.26B(-6.4%)
$11.45B(+14.3%)
Sep 2010
-
$6.68B(+37.1%)
$10.02B(+34.7%)
Jun 2010
-
$4.87B(-176.6%)
$7.44B(+5.1%)
Mar 2010
-
-$6.36B(-231.8%)
$7.08B(-57.3%)
Dec 2009
$16.59B(-9.1%)
$4.83B(+17.7%)
$16.59B(-6.5%)
Sep 2009
-
$4.10B(-9.1%)
$17.73B(+0.8%)
Jun 2009
-
$4.51B(+43.4%)
$17.59B(-2.9%)
Mar 2009
-
$3.15B(-47.3%)
$18.11B(-0.7%)
Dec 2008
$18.24B(+36.6%)
$5.97B(+51.1%)
$18.24B(+13.8%)
Sep 2008
-
$3.95B(-21.6%)
$16.03B(-4.3%)
Jun 2008
-
$5.04B(+54.1%)
$16.76B(+9.0%)
Mar 2008
-
$3.27B(-13.2%)
$15.38B(+15.2%)
Dec 2007
$13.35B
$3.77B(-19.5%)
$13.35B(-5.0%)
Sep 2007
-
$4.68B(+27.6%)
$14.06B(+5.0%)
DateAnnualQuarterlyTTM
Jun 2007
-
$3.67B(+194.9%)
$13.40B(-9.9%)
Mar 2007
-
$1.24B(-72.2%)
$14.88B(-15.4%)
Dec 2006
$17.59B(+19.4%)
$4.48B(+11.5%)
$17.59B(-1.5%)
Sep 2006
-
$4.01B(-22.0%)
$17.86B(+5.9%)
Jun 2006
-
$5.14B(+29.8%)
$16.85B(+8.7%)
Mar 2006
-
$3.96B(-16.4%)
$15.50B(+5.2%)
Dec 2005
$14.73B(-9.8%)
$4.74B(+57.2%)
$14.73B(-7.8%)
Sep 2005
-
$3.01B(-20.5%)
$15.99B(-11.9%)
Jun 2005
-
$3.79B(+18.7%)
$18.15B(+1.1%)
Mar 2005
-
$3.19B(-46.7%)
$17.95B(+9.9%)
Dec 2004
$16.34B(+39.3%)
$5.99B(+15.7%)
$16.34B(+10.9%)
Sep 2004
-
$5.18B(+44.1%)
$14.73B(+18.5%)
Jun 2004
-
$3.59B(+126.8%)
$12.43B(+13.3%)
Mar 2004
-
$1.58B(-63.9%)
$10.97B(-6.4%)
Dec 2003
$11.73B(+15.2%)
$4.38B(+52.6%)
$11.73B(+5.4%)
Sep 2003
-
$2.87B(+34.7%)
$11.13B(+5.2%)
Jun 2003
-
$2.13B(-8.7%)
$10.57B(-3.7%)
Mar 2003
-
$2.34B(-38.2%)
$10.98B(+7.9%)
Dec 2002
$10.18B(+11.0%)
$3.78B(+62.9%)
$10.18B(+15.9%)
Sep 2002
-
$2.32B(-8.7%)
$8.78B(-2.9%)
Jun 2002
-
$2.54B(+65.7%)
$9.04B(+1.7%)
Mar 2002
-
$1.53B(-35.6%)
$8.89B(-3.0%)
Dec 2001
$9.17B(+48.1%)
$2.38B(-7.6%)
$9.17B(-2.8%)
Sep 2001
-
$2.58B(+7.7%)
$9.44B(+3.6%)
Jun 2001
-
$2.40B(+32.1%)
$9.11B(+14.5%)
Mar 2001
-
$1.81B(-31.5%)
$7.96B(+28.4%)
Dec 2000
$6.20B(+13.2%)
$2.65B(+17.8%)
$6.20B(+14.4%)
Sep 2000
-
$2.25B(+80.8%)
$5.41B(+3.3%)
Jun 2000
-
$1.24B(+2292.3%)
$5.24B(-7.2%)
Mar 2000
-
$52.00M(-97.2%)
$5.65B(+3.2%)
Dec 1999
$5.47B(+5.6%)
$1.87B(-10.1%)
$5.47B(-24.5%)
Sep 1999
-
$2.08B(+25.7%)
$7.25B(+21.2%)
Jun 1999
-
$1.65B(-1432.3%)
$5.98B(+21.0%)
Mar 1999
-
-$124.00M(-103.4%)
$4.95B(-4.5%)
Dec 1998
$5.18B(+236.4%)
$3.65B(+350.8%)
$5.18B(+164.5%)
Sep 1998
-
$809.00M(+31.8%)
$1.96B(+23.4%)
Jun 1998
-
$614.00M(+453.2%)
$1.59B(+14.7%)
Mar 1998
-
$111.00M(-73.9%)
$1.38B(-10.1%)
Dec 1997
$1.54B(-21.5%)
$425.00M(-3.0%)
$1.54B(-12.7%)
Sep 1997
-
$438.00M(+6.8%)
$1.76B(-7.9%)
Jun 1997
-
$410.00M(+53.6%)
$1.92B(-4.6%)
Mar 1997
-
$267.00M(-58.9%)
$2.01B(+2.3%)
Dec 1996
$1.96B(+7.7%)
$650.00M(+10.4%)
$1.96B(-0.2%)
Sep 1996
-
$589.00M(+17.3%)
$1.97B(+9.5%)
Jun 1996
-
$502.00M(+127.1%)
$1.80B(+20.9%)
Mar 1996
-
$221.00M(-66.2%)
$1.48B(-18.5%)
Dec 1995
$1.82B(+22.4%)
$654.80M(+56.8%)
$1.82B(+10.5%)
Sep 1995
-
$417.60M(+118.4%)
$1.65B(+0.8%)
Jun 1995
-
$191.20M(-65.7%)
$1.63B(-9.2%)
Mar 1995
-
$557.80M(+15.9%)
$1.80B(+21.0%)
Dec 1994
$1.49B(+17.9%)
$481.20M(+19.0%)
$1.49B(-11.8%)
Sep 1994
-
$404.50M(+13.1%)
$1.69B(+5.2%)
Jun 1994
-
$357.50M(+45.7%)
$1.60B(+8.6%)
Mar 1994
-
$245.30M(-63.9%)
$1.48B(+16.9%)
Dec 1993
$1.26B(+56.5%)
$680.10M(+111.5%)
$1.26B(+34.9%)
Sep 1993
-
$321.60M(+39.9%)
$936.10M(+7.2%)
Jun 1993
-
$229.80M(+629.5%)
$873.60M(+7.3%)
Mar 1993
-
$31.50M(-91.1%)
$814.40M(+0.9%)
Dec 1992
$807.00M(-4.8%)
$353.20M(+36.3%)
$807.00M(-1.8%)
Sep 1992
-
$259.10M(+51.9%)
$821.40M(+11.9%)
Jun 1992
-
$170.60M(+607.9%)
$734.00M(-7.6%)
Mar 1992
-
$24.10M(-93.4%)
$794.80M(-6.2%)
Dec 1991
$847.60M(-1.5%)
$367.60M(+114.1%)
$847.60M(-4.1%)
Sep 1991
-
$171.70M(-25.8%)
$883.50M(+5.2%)
Jun 1991
-
$231.40M(+200.9%)
$840.10M(+1.8%)
Mar 1991
-
$76.90M(-80.9%)
$825.40M(-4.1%)
Dec 1990
$860.50M(+31.2%)
$403.50M(+214.5%)
$860.50M(+88.3%)
Sep 1990
-
$128.30M(-40.8%)
$457.00M(+39.0%)
Jun 1990
-
$216.70M(+93.5%)
$328.70M(+193.5%)
Mar 1990
-
$112.00M
$112.00M
Dec 1989
$655.80M
-
-

FAQ

  • What is Pfizer annual cash flow from operations?
  • What is the all time high annual CFO for Pfizer?
  • What is Pfizer annual CFO year-on-year change?
  • What is Pfizer quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Pfizer?
  • What is Pfizer quarterly CFO year-on-year change?
  • What is Pfizer TTM cash flow from operations?
  • What is the all time high TTM CFO for Pfizer?
  • What is Pfizer TTM CFO year-on-year change?

What is Pfizer annual cash flow from operations?

The current annual CFO of PFE is $12.74B

What is the all time high annual CFO for Pfizer?

Pfizer all-time high annual cash flow from operations is $32.58B

What is Pfizer annual CFO year-on-year change?

Over the past year, PFE annual cash flow from operations has changed by +$4.04B (+46.48%)

What is Pfizer quarterly cash flow from operations?

The current quarterly CFO of PFE is $2.33B

What is the all time high quarterly CFO for Pfizer?

Pfizer all-time high quarterly cash flow from operations is $11.30B

What is Pfizer quarterly CFO year-on-year change?

Over the past year, PFE quarterly cash flow from operations has changed by +$1.25B (+114.22%)

What is Pfizer TTM cash flow from operations?

The current TTM CFO of PFE is $13.99B

What is the all time high TTM CFO for Pfizer?

Pfizer all-time high TTM cash flow from operations is $34.58B

What is Pfizer TTM CFO year-on-year change?

Over the past year, PFE TTM cash flow from operations has changed by +$5.41B (+63.08%)
On this page